Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Free Articles

Week in Review: Mabwell Sells Ex-China Rights to Rare Disease Therapy in $412 Million Deal
Week in Review: AlphaGen and ArtBio Form China-US Radioligand Partnership
Week in Review: LianBio to Close Operations; Will Pay $528 Million to Shareholders
Week in Review: I-Mab Morphs into US-Only Company; Sells China Assets for $80 Million
Week in Review: Shanghai Inmagene Signs $230 Million Deal to Develop Two HutchMed Immunology Assets
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital